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Editorial:
Diagnosis of viral diseases in India: at the cross roads
In the last decade, epidemics of viral diseases have become one of the main concerns in public health.
Apart from the ever threatening influenza and the relatively recent human immunodeficiency virus
(HIV) infection, re-emergence of chikungunya fever and rapid increase in the incidence of dengue
fever, emergence of new viral diseases like swine flu, have all contributed to this concern. The
worrying mortality during epidemics and the morbidity due to post-infection sequelae along with
lack of specific antiviral drugs or vaccines have generated a fear complex in the minds of common
man and simultaneously threw challenges to the physicians and scientists in the areas of diagnosis
and therapy of these viral infections.
Diagnosis is one of the prime requirements in disease management. Diagnosis of viral diseases is
very crucial as it necessitates identification/estimation of either antigen or antigen specific antibodies
produced by the immune system. Definitive diagnosis of viral diseases is essential for recognizing
the occurrence of epidemics and for instituting appropriate treatment. Different types of diagnostic
tests ranging from the basic level to the most advanced are currently available in the commercial
market for the diagnosis of viral diseases.  Broadly, diagnostic tests used for viral diseases can be
classified in to: (i) tests involving direct specimen examination; (ii) viral isolation; and (iii)
serodiagnostic tests.
In tests based on direct specimen examination , the clinical specimen is examined directly for the
presence of virus antigen or viral genome using  methods, such as, electron microscopy morphology/
immune electron microscopy, light microscopy histopathological appearances (e.g., presence of
inclusion bodies), and molecular techniques for the detection of viral genomes. In tests based on
virus isolation techniques, the infectious virus is isolated from the clinical sample and cultured in the
embryonated eggs, animals or in cell-lines or cell-cultures. This is useful for further characterization
of viruses or development of vaccine production. In serodiagnostic tests, several serological methods
are being used to detect the viral antigens or their specific antibodies or other immunogens. In these
serodiagnostic  methods,  diagnosis can be made by the detection of rising titres of antibody between
acute and convalescent stage of infection or the detection of less specific immunoglobulin M (IgM)
or immunoglobulin  G (IgG). The various techniques used in serodiagnosis include complement
fixation test (CFT), haemagglutination inhibition (HI) test, immunofluorescence (IF) techniques,
neutralization tests, single radial haemolysis, enzyme linked immunosorbent assay (ELISA), particle
agglutination, western blot, recombinant immunoblot assay (RIBA) and  line immunoassay. Expertise
is essential to use the above techniques and these have become part of many advanced clinical
virology laboratories.
In general, the majority of common viral infections (e.g., viral hepatitis and HIV) can be diagnosed
in clinical specimens by using serodiagnostic methods.  However, in recent times, these traditional
diagnostic techniques are slowly becoming less useful or relevant in the management due to the non-
specificity in detecting various strains/ pathotypes or isolates or serotypes of the viruses. This is
especially true for the recently emerging viral diseases like swine flu, Nipah virus, Chikungunya
virus etc., to name a few. This is paving the way for more interest in molecular methods for the
detection of viral genome and these are getting established as the future diagnostic tests in virology.
The viral load and antiviral resistance or subtyping assays are now part of the biological monitoring
of patients chronically infected by several viruses. But viral genome studies are not yet used in
routine diagnostic work in a clinical virology laboratory. In the 21st century the molecular biology
techniques for the detection of viral genomes like  the nucleic probe based or genome amplification
based methods e.g., polymerse chain reaction (PCR) are expected to play an increasingly important
role in the clinical virology laboratory. PCR is the only amplification technique which is in common
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use and an extremely sensitive technique. It is possible to achieve a sensitivity to detect a single DNA
molecule in a clinical specimen.  PCR is being used increasingly for viral diagnosis in super specialty
clinics and there is availability of closed automated systems that could also perform quantification
e.g., real-time PCR (RT-PCR). This is expected to solve major part of diagnostic confusion that is
now prevailing in the identification of causative virus.
Classical molecular techniques such as dot-blot and Southern-blot depend on the use of specific
DNA/RNA probes for hybridization. The specificity of the reaction depends on the conditions used
for hybridization. These techniques may allow for the quantification of DNA/RNA present in the
specimen. However, it is often found that the sensitivity of these techniques is not better than
conventional viral diagnostic methods. Recent molecular techniques such as the polymerase chain
reaction (PCR), ligase chain reaction (LCR), nucleic acid based amplification (NASBA), loop mediated
isothermal amplification (LAMP) and branched DNA (bDNA) depend on some form of amplification,
either the target nucleic acid, or the signal itself. bDNA is essentially a conventional hybridization
technique with increased sensitivity. Other amplification techniques such as LCR and NASBA are
also being used to detect the viruses. Recently the microarray technique is being used for detection
of viruses in large scale.
Due to the viral genome variability or diversity in the environment, several strains of a virus emerge.
Due to this, the diagnostic utility of commercially available viral diagnostic tests is often seriously
impaired. This becomes the crux of the problem for diagnosing viral infection precisely even with
advanced techniques. Another drawback in the application of viral diagnostics in a clinical setting is
that the patient may come to the hospital during window period wherein absence of viral specific
antibodies results in a negative test report adding to the clinician's confusion.  In Indian scenario,
lack of awareness on viral diagnostic methods and limited access to viral diagnostic laboratory could
also contribute to underutilization of viral diagnostic tests by clinicians. Lack of expertise, non-
availability of needed equipment and excessive cost are additional factors of concern.  There is a
need to address these issues and the measures should include enhancing the awareness among clinicians
regarding the various diagnostic methods and developing algorithms for choosing the most appropriate
test(s) for ascertaining the virological diagnosis.
Keeping in view the recent outbreaks of several viral diseases in India, the Government of India has
started concentrating more on the viral infections, especially the vector borne diseases by launching
national vector borne disease control program. At present, the main thrust is on control of vectors.
It is expected that further growth of these program would obviously focus on better diagnosis in a
manner similar to National AIDS Control Program. We can see this in the twelfth plan.1 However, it
would also be necessary to focus more in training clinicians and popularizing the use of appropriate
diagnostic methods for early diagnosis of the viral diseases. There is also a need to develop molecular
diagnostic kits in India so as to contain costs.
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